A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity.

ABSTRACT:

Background and aim

Several studies have shown that bariatric surgery reduces long term mortality compared to medical weight loss therapy. In a previous study we have demonstrated that gastric banding (LAGB) is associated with reduced mortality in patients with and without diabetes, and with reduced incidence of obesity co-morbidities (cardiovascular disease, diabetes, and cancer) at a 17 year follow-up. The aim of this study was to verify at a longer time interval (23 years) mortality and incidence of co-morbidities in patients undergoing LAGB or medical weight loss therapy.

Patients and methods

As reported in the previous shorter-time study, medical records of obese patients [body mass index (BMI) > 35 kg/m² undergoing LAGB (n = 385; 52 with diabetes) or medical

SUBMITTER: Pontiroli AE 

PROVIDER: S-EPMC6311074 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature